변비 치료 시장 규모, 점유율, 성장 분석 : 치료법별, 투여 경로별, 환자 유형별, 유통경로별, 지역별 - 업계 예측(2026-2033년)

Global Constipation Treatment Market size was valued at USD 19.31 Billion in 2024 and is poised to grow from USD 20.49 Billion in 2025 to USD 32.9 Billion by 2033, growing at a CAGR of 6.1% during the forecast period (2026-2033).

The global constipation treatment market is experiencing significant growth driven by several key factors. An aging population has led to an increased prevalence of chronic constipation and gastrointestinal disorders, while a rise in opioid usage has resulted in a surge of opioid-induced constipation cases, escalating the need for targeted treatments. Consumers are increasingly favoring over-the-counter natural products, a trend supported by heightened awareness of gut health. Additionally, advancements in technology, such as digital health tracking and teleconsultation, are improving diagnosis and management, further fueling market momentum. However, challenges persist, including patient compliance issues due to laxative side effects, low awareness in economically disadvantaged areas, high therapy costs, and regulatory hurdles that slow product launches, complicating the landscape for both established companies and new entrants.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Constipation Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Constipation Treatment Market Segments Analysis

Global Constipation Treatment Market is segmented by Treatment Type, Route of Administration, Patient Type, Distribution Channel and region. Based on Treatment Type, the market is segmented into Pharmacological and Non-Pharmacological. Based on Route of Administration, the market is segmented into Oral, Rectal and Parenteral / Sub-cutaneous. Based on Patient Type, the market is segmented into Adults, Pediatrics and Geriatrics. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies & Drug Stores and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Constipation Treatment Market

The rising prevalence of gastrointestinal disorders, such as irritable bowel syndrome and chronic idiopathic constipation, significantly propels the growth of the constipation treatment market. Contributing factors include sedentary lifestyles, poor dietary choices, and an increasingly aging demographic. These elements combine to create a higher incidence of constipation-related issues, which in turn fuels the demand for both prescription and over-the-counter treatment options. As awareness of these conditions grows, coupled with a focus on improved health and wellness, it is anticipated that the need for effective constipation treatments will remain robust, driving further developments and innovations within the market.

Restraints in the Global Constipation Treatment Market

The Global Constipation Treatment market faces challenges due to the prolonged use of laxatives and certain prescription medications, which often lead to adverse effects such as dependency, electrolyte imbalances, and gastrointestinal discomfort. These complications tend to reduce patient adherence to treatment regimens, inhibiting the overall effectiveness of long-term management strategies. Consequently, this situation is prompting a shift toward more acceptable and safer alternatives in constipation care, while simultaneously fostering the development and adoption of non-pharmacological therapies. As a result, healthcare providers are increasingly encouraged to explore and prioritize treatment options that minimize potential side effects and enhance patient well-being.

Market Trends of the Global Constipation Treatment Market

The Global Constipation Treatment market is increasingly embracing personalized gut health solutions, driven by advancements in microbiome research and artificial intelligence. This trend reflects a significant shift toward customized treatment options that cater to individual gut profiles, lifestyle factors, and ongoing symptom tracking. By tailoring interventions to meet specific patient needs, the market aims to enhance treatment efficacy and boost patient adherence, thereby improving overall outcomes. As technology continues to integrate into healthcare, the emphasis on personalization signifies a transformative direction in constipation management, aligning with broader trends in patient-centered care and precision medicine within the healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Constipation Treatment Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Pharmacological
  • Laxatives
  • Chloride Channel Activators
  • GC-C Agonists
  • 5-HT4 Agonists
  • Peripherally Acting µ-Opioid Receptor Antagonists
  • Others
• Non-Pharmacological
  • Dietary Fiber Supplements
  • Biofeedback & Physical Therapy
  • Fecal Microbiota Transplant
  • Digital Therapeutics

Global Constipation Treatment Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Rectal
• Parenteral / Sub-cutaneous

Global Constipation Treatment Market Size by Patient Type & CAGR (2026-2033)

• Market Overview
• Adults
• Pediatrics
• Geriatrics

Global Constipation Treatment Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies & Drug Stores
• Online Pharmacies

Global Constipation Treatment Market Size & CAGR (2026-2033)

• North America (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • US
  • Canada
• Europe (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Route of Administration, Patient Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• AbbVie Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ironwood Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Procter & Gamble (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shionogi & Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prestige Consumer Healthcare Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Health Science (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ardelyx Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cosmo Pharmaceuticals (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C.B. Fleet Company Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations